APO Research
Talk to an analyst

APO RESEARCH · REPORT

Hemorrhagic Septicemia Vaccines

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Hemorrhagic Septicemia Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

22 December 2025198 pages

Choose your research edition.

Industry ResearchHemorrhagic Septicemia Vaccines Industry Research Report 2026136 pages · $2,950 USDIndustry Growth & TrendsGlobal Hemorrhagic Septicemia Vaccines Industry Growth and Trends Forecast to 2032110 pages · $3,450 USDMarket StructureGlobal Hemorrhagic Septicemia Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Hemorrhagic Septicemia Vaccines Market Outlook and Growth Opportunities 2026202 pages · $4,250 USDMarket Analysis & ForecastGlobal Hemorrhagic Septicemia Vaccines Market Analysis and Forecast 2026-2032202 pages · $4,950 USD

Market perspective

The global Hemorrhagic Septicemia Vaccines market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Hemorrhagic Septicemia Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Hemorrhagic Septicemia Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Hemorrhagic Septicemia Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Hemorrhagic Septicemia Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Hemorrhagic Septicemia Vaccines include Zoetis, Vecol, National Veterinary Research Institute, Limor de Colombia, Laboratorios Ovejero, Laboratorios Laverlam, LABIOFAM, Intervac (PVT) Ltd and Institute of Veterinary Preventive Medicine, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Hemorrhagic Septicemia Vaccines market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Hemorrhagic Septicemia Vaccines and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Hemorrhagic Septicemia Vaccines sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Hemorrhagic Septicemia Vaccines market size, projected growth trends, production technologies, key applications, and end-use industries.

Hemorrhagic Septicemia Vaccines Segment by Company

Zoetis

Vecol

National Veterinary Research Institute

Limor de Colombia

Laboratorios Ovejero

Laboratorios Laverlam

LABIOFAM

Intervac (PVT) Ltd

Institute of Veterinary Preventive Medicine

Institute of Animal Health and Veterinary Biologicals

Indian Immunologicals Limited

FATRO

Ceva Santé Animale

C.A. Laboratorios Asociados (CALA)

Brilliant Bio Pharma

Bio-Labs (PVT) Limited

Hemorrhagic Septicemia Vaccines Segment by Type

Oil–adjuvant Vaccines

Aluminum hydroxide-adjuvant Vaccines

Hemorrhagic Septicemia Vaccines Segment by Application

Cattle

Buffaloes

Hemorrhagic Septicemia Vaccines Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hemorrhagic Septicemia Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Hemorrhagic Septicemia Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hemorrhagic Septicemia Vaccines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Hemorrhagic Septicemia Vaccines market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Hemorrhagic Septicemia Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Hemorrhagic Septicemia Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Hemorrhagic Septicemia Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Hemorrhagic Septicemia Vaccines Industry Trends Table 2. Hemorrhagic Septicemia Vaccines Industry Drivers Table 3. Hemorrhagic Septicemia Vaccines Industry Opportunities and Challenges Table 4. Hemorrhagic Septicemia Vaccines Industry Restraints Table 5. Global Hemorrhagic Septicemia Vaccines Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Hemorrhagic Septicemia Vaccines Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Hemorrhagic Septicemia Vaccines Sales by Manufacturers (m units) & (2021-2026) Table 8. Global Hemorrhagic Septicemia Vaccines Sales Market Share by Manufacturers Table 9. Global Hemorrhagic Septicemia Vaccines Average Sales Price (US$/k unit) of Manufacturers (2021-2026) Table 10. Global Hemorrhagic Septicemia Vaccines Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Hemorrhagic Septicemia Vaccines Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Hemorrhagic Septicemia Vaccines Manufacturers, Product Type & Application Table 13. Global Hemorrhagic Septicemia Vaccines Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Hemorrhagic Septicemia Vaccines by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Oil–adjuvant Vaccines Table 17. Major Manufacturers of Aluminum hydroxide-adjuvant Vaccines Table 18. Global Hemorrhagic Septicemia Vaccines Sales by Type 2021 VS 2025 VS 2032 (m units) Table 19. Global Hemorrhagic Septicemia Vaccines Sales by Type (2021-2026) & (m units) Table 20. Global Hemorrhagic Septicemia Vaccines Sales by Type (2027-2032) & (m units) Table 21. Global Hemorrhagic Septicemia Vaccines Sales Market Share by Type (2021-2026) Table 22. Global Hemorrhagic Septicemia Vaccines Sales Market Share by Type (2027-2032) Table 23. Global Hemorrhagic Septicemia Vaccines Revenue by Type 2021 VS 2025 VS 2032 (m units) Table 24. Global Hemorrhagic Septicemia Vaccines Revenue by Type (2021-2026) & (m units) Table 25. Global Hemorrhagic Septicemia Vaccines Revenue by Type (2027-2032) & (m units) Table 26. Global Hemorrhagic Septicemia Vaccines Revenue Market Share by Type (2021-2026) Table 27. Global Hemorrhagic Septicemia Vaccines Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Cattle Table 29. Major Manufacturers of Buffaloes Table 30. Global Hemorrhagic Septicemia Vaccines Sales by Application 2021 VS 2025 VS 2032 (m units) Table 31. Global Hemorrhagic Septicemia Vaccines Sales by Application (2021-2026) & (m units) Table 32. Global Hemorrhagic Septicemia Vaccines Sales by Application (2027-2032) & (m units) Table 33. Global Hemorrhagic Septicemia Vaccines Sales Market Share by Application (2021-2026) Table 34. Global Hemorrhagic Septicemia Vaccines Sales Market Share by Application (2027-2032) Table 35. Global Hemorrhagic Septicemia Vaccines Revenue by Application 2021 VS 2025 VS 2032 (m units) Table 36. Global Hemorrhagic Septicemia Vaccines Revenue by Application (2021-2026) & (m units) Table 37. Global Hemorrhagic Septicemia Vaccines Revenue by Application (2027-2032) & (m units) Table 38. Global Hemorrhagic Septicemia Vaccines Revenue Market Share by Application (2021-2026) Table 39. Global Hemorrhagic Septicemia Vaccines Revenue Market Share by Application (2027-2032) Table 40. Global Hemorrhagic Septicemia Vaccines Sales by Region: 2021 VS 2025 VS 2032 (m units) Table 41. Global Hemorrhagic Septicemia Vaccines Sales by Region (2021-2026) & (m units) Table 42. Global Hemorrhagic Septicemia Vaccines Sales Market Share by Region (2021-2026) Table 43. Global Hemorrhagic Septicemia Vaccines Sales Forecasted by Region (2027-2032) & (m units) Table 44. Global Hemorrhagic Septicemia Vaccines Sales Forecasted Market Share by Region (2027-2032) Table 45. North America Hemorrhagic Septicemia Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (m units) Table 46. North America Hemorrhagic Septicemia Vaccines Sales by Country (2021-2026) & (m units) Table 47. North America Hemorrhagic Septicemia Vaccines Sales by Country (2027-2032) & (m units) Table 48. Europe Hemorrhagic Septicemia Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (m units) Table 49. Europe Hemorrhagic Septicemia Vaccines Sales by Country (2021-2026) & (m units) Table 50. Europe Hemorrhagic Septicemia Vaccines Sales by Country (2027-2032) & (m units) Table 51. Asia Pacific Hemorrhagic Septicemia Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (m units) Table 52. Asia Pacific Hemorrhagic Septicemia Vaccines Sales by Country (2021-2026) & (m units) Table 53. Asia Pacific Hemorrhagic Septicemia Vaccines Sales by Country (2027-2032) & (m units) Table 54. South America, Middle East and Africa Hemorrhagic Septicemia Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (m units) Table 55. South America, Middle East and Africa Hemorrhagic Septicemia Vaccines Sales by Country (2021-2026) & (m units) Table 56. South America, Middle East and Africa Hemorrhagic Septicemia Vaccines Sales by Country (2027-2032) & (m units) Table 57. Global Hemorrhagic Septicemia Vaccines Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Hemorrhagic Septicemia Vaccines Revenue by Region (2021-2026) & (US$ Million) Table 59. Global Hemorrhagic Septicemia Vaccines Revenue by Region (2027-2032) & (US$ Million) Table 60. Global Hemorrhagic Septicemia Vaccines Revenue Market Share by Region (2021-2026) Table 61. Global Hemorrhagic Septicemia Vaccines Revenue Market Share by Region (2027-2032) Table 62. Zoetis Company Information Table 63. Zoetis Business Overview Table 64. Zoetis Hemorrhagic Septicemia Vaccines Sales (m units), Price (US$/k unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. Zoetis Hemorrhagic Septicemia Vaccines Product Portfolio Table 66. Zoetis Recent Development Table 67. Vecol Company Information Table 68. Vecol Business Overview Table 69. Vecol Hemorrhagic Septicemia Vaccines Sales (m units), Price (US$/k unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Vecol Hemorrhagic Septicemia Vaccines Product Portfolio Table 71. Vecol Recent Development Table 72. National Veterinary Research Institute Company Information Table 73. National Veterinary Research Institute Business Overview Table 74. National Veterinary Research Institute Hemorrhagic Septicemia Vaccines Sales (m units), Price (US$/k unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. National Veterinary Research Institute Hemorrhagic Septicemia Vaccines Product Portfolio Table 76. National Veterinary Research Institute Recent Development Table 77. Limor de Colombia Company Information Table 78. Limor de Colombia Business Overview Table 79. Limor de Colombia Hemorrhagic Septicemia Vaccines Sales (m units), Price (US$/k unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Limor de Colombia Hemorrhagic Septicemia Vaccines Product Portfolio Table 81. Limor de Colombia Recent Development Table 82. Laboratorios Ovejero Company Information Table 83. Laboratorios Ovejero Business Overview Table 84. Laboratorios Ovejero Hemorrhagic Septicemia Vaccines Sales (m units), Price (US$/k unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Laboratorios Ovejero Hemorrhagic Septicemia Vaccines Product Portfolio Table 86. Laboratorios Ovejero Recent Development Table 87. Laboratorios Laverlam Company Information Table 88. Laboratorios Laverlam Business Overview Table 89. Laboratorios Laverlam Hemorrhagic Septicemia Vaccines Sales (m units), Price (US$/k unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Laboratorios Laverlam Hemorrhagic Septicemia Vaccines Product Portfolio Table 91. Laboratorios Laverlam Recent Development Table 92. LABIOFAM Company Information Table 93. LABIOFAM Business Overview Table 94. LABIOFAM Hemorrhagic Septicemia Vaccines Sales (m units), Price (US$/k unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 95. LABIOFAM Hemorrhagic Septicemia Vaccines Product Portfolio Table 96. LABIOFAM Recent Development Table 97. Intervac (PVT) Ltd Company Information Table 98. Intervac (PVT) Ltd Business Overview Table 99. Intervac (PVT) Ltd Hemorrhagic Septicemia Vaccines Sales (m units), Price (US$/k unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 100. Intervac (PVT) Ltd Hemorrhagic Septicemia Vaccines Product Portfolio Table 101. Intervac (PVT) Ltd Recent Development Table 102. Institute of Veterinary Preventive Medicine Company Information Table 103. Institute of Veterinary Preventive Medicine Business Overview Table 104. Institute of Veterinary Preventive Medicine Hemorrhagic Septicemia Vaccines Sales (m units), Price (US$/k unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 105. Institute of Veterinary Preventive Medicine Hemorrhagic Septicemia Vaccines Product Portfolio Table 106. Institute of Veterinary Preventive Medicine Recent Development Table 107. Institute of Animal Health and Veterinary Biologicals Company Information Table 108. Institute of Animal Health and Veterinary Biologicals Business Overview Table 109. Institute of Animal Health and Veterinary Biologicals Hemorrhagic Septicemia Vaccines Sales (m units), Price (US$/k unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 110. Institute of Animal Health and Veterinary Biologicals Hemorrhagic Septicemia Vaccines Product Portfolio Table 111. Institute of Animal Health and Veterinary Biologicals Recent Development Table 112. Indian Immunologicals Limited Company Information Table 113. Indian Immunologicals Limited Business Overview Table 114. Indian Immunologicals Limited Hemorrhagic Septicemia Vaccines Sales (m units), Price (US$/k unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 115. Indian Immunologicals Limited Hemorrhagic Septicemia Vaccines Product Portfolio Table 116. Indian Immunologicals Limited Recent Development Table 117. FATRO Company Information Table 118. FATRO Business Overview Table 119. FATRO Hemorrhagic Septicemia Vaccines Sales (m units), Price (US$/k unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 120. FATRO Hemorrhagic Septicemia Vaccines Product Portfolio Table 121. FATRO Recent Development Table 122. Ceva Santé Animale Company Information Table 123. Ceva Santé Animale Business Overview Table 124. Ceva Santé Animale Hemorrhagic Septicemia Vaccines Sales (m units), Price (US$/k unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 125. Ceva Santé Animale Hemorrhagic Septicemia Vaccines Product Portfolio Table 126. Ceva Santé Animale Recent Development Table 127. C.A. Laboratorios Asociados (CALA) Company Information Table 128. C.A. Laboratorios Asociados (CALA) Business Overview Table 129. C.A. Laboratorios Asociados (CALA) Hemorrhagic Septicemia Vaccines Sales (m units), Price (US$/k unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 130. C.A. Laboratorios Asociados (CALA) Hemorrhagic Septicemia Vaccines Product Portfolio Table 131. C.A. Laboratorios Asociados (CALA) Recent Development Table 132. Brilliant Bio Pharma Company Information Table 133. Brilliant Bio Pharma Business Overview Table 134. Brilliant Bio Pharma Hemorrhagic Septicemia Vaccines Sales (m units), Price (US$/k unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 135. Brilliant Bio Pharma Hemorrhagic Septicemia Vaccines Product Portfolio Table 136. Brilliant Bio Pharma Recent Development Table 137. Bio-Labs (PVT) Limited Company Information Table 138. Bio-Labs (PVT) Limited Business Overview Table 139. Bio-Labs (PVT) Limited Hemorrhagic Septicemia Vaccines Sales (m units), Price (US$/k unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 140. Bio-Labs (PVT) Limited Hemorrhagic Septicemia Vaccines Product Portfolio Table 141. Bio-Labs (PVT) Limited Recent Development Table 142. Key Raw Materials Table 143. Raw Materials Key Suppliers Table 144. Hemorrhagic Septicemia Vaccines Distributors List Table 145. Hemorrhagic Septicemia Vaccines Customers List Table 146. Research Programs/Design for This Report Table 147. Authors List of This Report Table 148. Secondary Sources Table 149. Primary Sources List of Figures Figure 1. Hemorrhagic Septicemia Vaccines Product Image Figure 2. Global Hemorrhagic Septicemia Vaccines Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Hemorrhagic Septicemia Vaccines Market Size (2021-2032) & (US$ Million) Figure 4. Global Hemorrhagic Septicemia Vaccines Sales (2021-2032) & (m units) Figure 5. Global Hemorrhagic Septicemia Vaccines Average Price (US$/k unit) & (2021-2032) Figure 6. Global Top 5 and 10 Hemorrhagic Septicemia Vaccines Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Oil–adjuvant Vaccines Image Figure 9. Aluminum hydroxide-adjuvant Vaccines Image Figure 10. Global Hemorrhagic Septicemia Vaccines Sales by Type (2021 VS 2025 VS 2032) & (m units) Figure 11. Global Hemorrhagic Septicemia Vaccines Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Hemorrhagic Septicemia Vaccines Sales Market Share by Type (2021-2032) Figure 13. Global Hemorrhagic Septicemia Vaccines Revenue by Type (2021 VS 2025 VS 2032) & (m units) Figure 14. Global Hemorrhagic Septicemia Vaccines Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Hemorrhagic Septicemia Vaccines Revenue Market Share by Type (2021-2032) Figure 16. Cattle Image Figure 17. Buffaloes Image Figure 18. Global Hemorrhagic Septicemia Vaccines Sales by Application (2021 VS 2025 VS 2032) & (m units) Figure 19. Global Hemorrhagic Septicemia Vaccines Sales Market Share 2021 VS 2025 VS 2032 Figure 20. Global Hemorrhagic Septicemia Vaccines Sales Market Share by Application (2021-2032) Figure 21. Global Hemorrhagic Septicemia Vaccines Revenue by Application (2021 VS 2025 VS 2032) & (m units) Figure 22. Global Hemorrhagic Septicemia Vaccines Revenue Market Share 2021 VS 2025 VS 2032 Figure 23. Global Hemorrhagic Septicemia Vaccines Revenue Market Share by Application (2021-2032) Figure 24. North America Hemorrhagic Septicemia Vaccines Sales and Growth Rate (2021-2032) & (m units) Figure 25. North America Hemorrhagic Septicemia Vaccines Sales Market Share by Country (2021-2032) Figure 26. U.S. Hemorrhagic Septicemia Vaccines Sales and Growth Rate (2021-2032) & (m units) Figure 27. Canada Hemorrhagic Septicemia Vaccines Sales and Growth Rate (2021-2032) & (m units) Figure 28. Mexico Hemorrhagic Septicemia Vaccines Sales and Growth Rate (2021-2032) & (m units) Figure 29. Europe Hemorrhagic Septicemia Vaccines Sales and Growth Rate (2021-2032) & (m units) Figure 30. Europe Hemorrhagic Septicemia Vaccines Sales Market Share by Country (2021-2032) Figure 31. Germany Hemorrhagic Septicemia Vaccines Sales and Growth Rate (2021-2032) & (m units) Figure 32. France Hemorrhagic Septicemia Vaccines Sales and Growth Rate (2021-2032) & (m units) Figure 33. U.K. Hemorrhagic Septicemia Vaccines Sales and Growth Rate (2021-2032) & (m units) Figure 34. Italy Hemorrhagic Septicemia Vaccines Sales and Growth Rate (2021-2032) & (m units) Figure 35. Netherlands Hemorrhagic Septicemia Vaccines Sales and Growth Rate (2021-2032) & (m units) Figure 36. Asia Pacific Hemorrhagic Septicemia Vaccines Sales and Growth Rate (2021-2032) & (m units) Figure 37. Asia Pacific Hemorrhagic Septicemia Vaccines Sales Market Share by Country (2021-2032) Figure 38. China Hemorrhagic Septicemia Vaccines Sales and Growth Rate (2021-2032) & (m units) Figure 39. Japan Hemorrhagic Septicemia Vaccines Sales and Growth Rate (2021-2032) & (m units) Figure 40. South Korea Hemorrhagic Septicemia Vaccines Sales and Growth Rate (2021-2032) & (m units) Figure 41. Southeast Asia Hemorrhagic Septicemia Vaccines Sales and Growth Rate (2021-2032) & (m units) Figure 42. India Hemorrhagic Septicemia Vaccines Sales and Growth Rate (2021-2032) & (m units) Figure 43. Australia Hemorrhagic Septicemia Vaccines Sales and Growth Rate (2021-2032) & (m units) Figure 44. South America, Middle East and Africa Hemorrhagic Septicemia Vaccines Sales and Growth Rate (2021-2032) & (m units) Figure 45. South America, Middle East and Africa Hemorrhagic Septicemia Vaccines Sales Market Share by Country (2021-2032) Figure 46. Brazil Hemorrhagic Septicemia Vaccines Sales and Growth Rate (2021-2032) & (m units) Figure 47. South Africa Hemorrhagic Septicemia Vaccines Sales and Growth Rate (2021-2032) & (m units) Figure 48. Saudi Arabia Hemorrhagic Septicemia Vaccines Sales and Growth Rate (2021-2032) & (m units) Figure 49. Turkey Hemorrhagic Septicemia Vaccines Sales and Growth Rate (2021-2032) & (m units) Figure 50. Argentina Hemorrhagic Septicemia Vaccines Sales and Growth Rate (2021-2032) & (m units) Figure 51. UAE Hemorrhagic Septicemia Vaccines Sales and Growth Rate (2021-2032) & (m units) Figure 52. Egypt Hemorrhagic Septicemia Vaccines Sales and Growth Rate (2021-2032) & (m units) Figure 53. Chile Hemorrhagic Septicemia Vaccines Sales and Growth Rate (2021-2032) & (m units) Figure 54. Global Hemorrhagic Septicemia Vaccines Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Global Hemorrhagic Septicemia Vaccines Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 56. North America Hemorrhagic Septicemia Vaccines Revenue (2021-2032) & (US$ Million) Figure 57. North America Hemorrhagic Septicemia Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 58. Europe Hemorrhagic Septicemia Vaccines Revenue (2021-2032) & (US$ Million) Figure 59. Europe Hemorrhagic Septicemia Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Asia-Pacific Hemorrhagic Septicemia Vaccines Revenue (2021-2032) & (US$ Million) Figure 61. Asia-Pacific Hemorrhagic Septicemia Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. South America, Middle East and Africa Hemorrhagic Septicemia Vaccines Revenue (2021-2032) & (US$ Million) Figure 63. South America, Middle East and Africa Hemorrhagic Septicemia Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Hemorrhagic Septicemia Vaccines Value Chain Figure 65. Manufacturing Cost Structure Figure 66. Hemorrhagic Septicemia Vaccines Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Oil–adjuvant Vaccines
  • Aluminum hydroxide-adjuvant Vaccines
Applications
  • Cattle
  • Buffaloes
Companies covered
  • Zoetis
  • Vecol
  • National Veterinary Research Institute
  • Limor de Colombia
  • Laboratorios Ovejero
  • Laboratorios Laverlam
  • LABIOFAM
  • Intervac (PVT) Ltd
  • Institute of Veterinary Preventive Medicine
  • Institute of Animal Health and Veterinary Biologicals
  • Indian Immunologicals Limited
  • FATRO
  • Ceva Santé Animale
  • C.A. Laboratorios Asociados (CALA)
  • Brilliant Bio Pharma
  • Bio-Labs (PVT) Limited

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Hemorrhagic Septicemia Vaccines Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Hemorrhagic Septicemia Vaccines Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Hemorrhagic Septicemia Vaccines Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Hemorrhagic Septicemia Vaccines Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Hemorrhagic Septicemia Vaccines Market Dynamics
  1. 2.1 Hemorrhagic Septicemia Vaccines Industry Trends
  2. 2.2 Hemorrhagic Septicemia Vaccines Industry Drivers
  3. 2.3 Hemorrhagic Septicemia Vaccines Industry Opportunities and Challenges
  4. 2.4 Hemorrhagic Septicemia Vaccines Industry Restraints
3 Hemorrhagic Septicemia Vaccines Market by Manufacturers
  1. 3.1 Global Hemorrhagic Septicemia Vaccines Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Hemorrhagic Septicemia Vaccines Sales by Manufacturers (2021-2026)
  3. 3.3 Global Hemorrhagic Septicemia Vaccines Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Hemorrhagic Septicemia Vaccines Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Hemorrhagic Septicemia Vaccines Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Hemorrhagic Septicemia Vaccines Manufacturers, Product Type & Application
  7. 3.7 Global Hemorrhagic Septicemia Vaccines Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Hemorrhagic Septicemia Vaccines Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Hemorrhagic Septicemia Vaccines Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Hemorrhagic Septicemia Vaccines Tier 1, Tier 2, and Tier 3
4 Hemorrhagic Septicemia Vaccines Market by Type
  1. 4.1 Hemorrhagic Septicemia Vaccines Type Introduction
  2. 4.1.1 Oil–adjuvant Vaccines
  3. 4.1.2 Aluminum hydroxide-adjuvant Vaccines
  4. 4.2 Global Hemorrhagic Septicemia Vaccines Sales by Type
  5. 4.2.1 Global Hemorrhagic Septicemia Vaccines Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Hemorrhagic Septicemia Vaccines Sales by Type (2021-2032)
  7. 4.2.3 Global Hemorrhagic Septicemia Vaccines Sales Market Share by Type (2021-2032)
  8. 4.3 Global Hemorrhagic Septicemia Vaccines Revenue by Type
  9. 4.3.1 Global Hemorrhagic Septicemia Vaccines Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Hemorrhagic Septicemia Vaccines Revenue by Type (2021-2032)
  11. 4.3.3 Global Hemorrhagic Septicemia Vaccines Revenue Market Share by Type (2021-2032)
5 Hemorrhagic Septicemia Vaccines Market by Application
  1. 5.1 Hemorrhagic Septicemia Vaccines Application Introduction
  2. 5.1.1 Cattle
  3. 5.1.2 Buffaloes
  4. 5.2 Global Hemorrhagic Septicemia Vaccines Sales by Application
  5. 5.2.1 Global Hemorrhagic Septicemia Vaccines Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Hemorrhagic Septicemia Vaccines Sales by Application (2021-2032)
  7. 5.2.3 Global Hemorrhagic Septicemia Vaccines Sales Market Share by Application (2021-2032)
  8. 5.3 Global Hemorrhagic Septicemia Vaccines Revenue by Application
  9. 5.3.1 Global Hemorrhagic Septicemia Vaccines Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Hemorrhagic Septicemia Vaccines Revenue by Application (2021-2032)
  11. 5.3.3 Global Hemorrhagic Septicemia Vaccines Revenue Market Share by Application (2021-2032)
6 Global Hemorrhagic Septicemia Vaccines Sales by Region
  1. 6.1 Global Hemorrhagic Septicemia Vaccines Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Hemorrhagic Septicemia Vaccines Sales by Region (2021-2032)
  3. 6.2.1 Global Hemorrhagic Septicemia Vaccines Sales by Region (2021-2026)
  4. 6.2.2 Global Hemorrhagic Septicemia Vaccines Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Hemorrhagic Septicemia Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Hemorrhagic Septicemia Vaccines Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Hemorrhagic Septicemia Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Hemorrhagic Septicemia Vaccines Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Hemorrhagic Septicemia Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Hemorrhagic Septicemia Vaccines Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Hemorrhagic Septicemia Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Hemorrhagic Septicemia Vaccines Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Hemorrhagic Septicemia Vaccines Revenue by Region
  1. 7.1 Global Hemorrhagic Septicemia Vaccines Revenue by Region
  2. 7.1.1 Global Hemorrhagic Septicemia Vaccines Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Hemorrhagic Septicemia Vaccines Revenue by Region (2021-2026)
  4. 7.1.3 Global Hemorrhagic Septicemia Vaccines Revenue by Region (2027-2032)
  5. 7.1.4 Global Hemorrhagic Septicemia Vaccines Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Hemorrhagic Septicemia Vaccines Revenue (2021-2032)
  8. 7.2.2 North America Hemorrhagic Septicemia Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Hemorrhagic Septicemia Vaccines Revenue (2021-2032)
  11. 7.3.2 Europe Hemorrhagic Septicemia Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Hemorrhagic Septicemia Vaccines Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Hemorrhagic Septicemia Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Hemorrhagic Septicemia Vaccines Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Hemorrhagic Septicemia Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Zoetis
  2. 8.1.1 Zoetis Company Information
  3. 8.1.2 Zoetis Business Overview
  4. 8.1.3 Zoetis Hemorrhagic Septicemia Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Zoetis Hemorrhagic Septicemia Vaccines Product Portfolio
  6. 8.1.5 Zoetis Recent Developments
  7. 8.2 Vecol
  8. 8.2.1 Vecol Company Information
  9. 8.2.2 Vecol Business Overview
  10. 8.2.3 Vecol Hemorrhagic Septicemia Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Vecol Hemorrhagic Septicemia Vaccines Product Portfolio
  12. 8.2.5 Vecol Recent Developments
  13. 8.3 National Veterinary Research Institute
  14. 8.3.1 National Veterinary Research Institute Company Information
  15. 8.3.2 National Veterinary Research Institute Business Overview
  16. 8.3.3 National Veterinary Research Institute Hemorrhagic Septicemia Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 National Veterinary Research Institute Hemorrhagic Septicemia Vaccines Product Portfolio
  18. 8.3.5 National Veterinary Research Institute Recent Developments
  19. 8.4 Limor de Colombia
  20. 8.4.1 Limor de Colombia Company Information
  21. 8.4.2 Limor de Colombia Business Overview
  22. 8.4.3 Limor de Colombia Hemorrhagic Septicemia Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Limor de Colombia Hemorrhagic Septicemia Vaccines Product Portfolio
  24. 8.4.5 Limor de Colombia Recent Developments
  25. 8.5 Laboratorios Ovejero
  26. 8.5.1 Laboratorios Ovejero Company Information
  27. 8.5.2 Laboratorios Ovejero Business Overview
  28. 8.5.3 Laboratorios Ovejero Hemorrhagic Septicemia Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Laboratorios Ovejero Hemorrhagic Septicemia Vaccines Product Portfolio
  30. 8.5.5 Laboratorios Ovejero Recent Developments
  31. 8.6 Laboratorios Laverlam
  32. 8.6.1 Laboratorios Laverlam Company Information
  33. 8.6.2 Laboratorios Laverlam Business Overview
  34. 8.6.3 Laboratorios Laverlam Hemorrhagic Septicemia Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Laboratorios Laverlam Hemorrhagic Septicemia Vaccines Product Portfolio
  36. 8.6.5 Laboratorios Laverlam Recent Developments
  37. 8.7 LABIOFAM
  38. 8.7.1 LABIOFAM Company Information
  39. 8.7.2 LABIOFAM Business Overview
  40. 8.7.3 LABIOFAM Hemorrhagic Septicemia Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 LABIOFAM Hemorrhagic Septicemia Vaccines Product Portfolio
  42. 8.7.5 LABIOFAM Recent Developments
  43. 8.8 Intervac (PVT) Ltd
  44. 8.8.1 Intervac (PVT) Ltd Company Information
  45. 8.8.2 Intervac (PVT) Ltd Business Overview
  46. 8.8.3 Intervac (PVT) Ltd Hemorrhagic Septicemia Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Intervac (PVT) Ltd Hemorrhagic Septicemia Vaccines Product Portfolio
  48. 8.8.5 Intervac (PVT) Ltd Recent Developments
  49. 8.9 Institute of Veterinary Preventive Medicine
  50. 8.9.1 Institute of Veterinary Preventive Medicine Company Information
  51. 8.9.2 Institute of Veterinary Preventive Medicine Business Overview
  52. 8.9.3 Institute of Veterinary Preventive Medicine Hemorrhagic Septicemia Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Institute of Veterinary Preventive Medicine Hemorrhagic Septicemia Vaccines Product Portfolio
  54. 8.9.5 Institute of Veterinary Preventive Medicine Recent Developments
  55. 8.10 Institute of Animal Health and Veterinary Biologicals
  56. 8.10.1 Institute of Animal Health and Veterinary Biologicals Company Information
  57. 8.10.2 Institute of Animal Health and Veterinary Biologicals Business Overview
  58. 8.10.3 Institute of Animal Health and Veterinary Biologicals Hemorrhagic Septicemia Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Institute of Animal Health and Veterinary Biologicals Hemorrhagic Septicemia Vaccines Product Portfolio
  60. 8.10.5 Institute of Animal Health and Veterinary Biologicals Recent Developments
  61. 8.11 Indian Immunologicals Limited
  62. 8.11.1 Indian Immunologicals Limited Company Information
  63. 8.11.2 Indian Immunologicals Limited Business Overview
  64. 8.11.3 Indian Immunologicals Limited Hemorrhagic Septicemia Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Indian Immunologicals Limited Hemorrhagic Septicemia Vaccines Product Portfolio
  66. 8.11.5 Indian Immunologicals Limited Recent Developments
  67. 8.12 FATRO
  68. 8.12.1 FATRO Company Information
  69. 8.12.2 FATRO Business Overview
  70. 8.12.3 FATRO Hemorrhagic Septicemia Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 FATRO Hemorrhagic Septicemia Vaccines Product Portfolio
  72. 8.12.5 FATRO Recent Developments
  73. 8.13 Ceva Santé Animale
  74. 8.13.1 Ceva Santé Animale Company Information
  75. 8.13.2 Ceva Santé Animale Business Overview
  76. 8.13.3 Ceva Santé Animale Hemorrhagic Septicemia Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Ceva Santé Animale Hemorrhagic Septicemia Vaccines Product Portfolio
  78. 8.13.5 Ceva Santé Animale Recent Developments
  79. 8.14 C.A. Laboratorios Asociados (CALA)
  80. 8.14.1 C.A. Laboratorios Asociados (CALA) Company Information
  81. 8.14.2 C.A. Laboratorios Asociados (CALA) Business Overview
  82. 8.14.3 C.A. Laboratorios Asociados (CALA) Hemorrhagic Septicemia Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 C.A. Laboratorios Asociados (CALA) Hemorrhagic Septicemia Vaccines Product Portfolio
  84. 8.14.5 C.A. Laboratorios Asociados (CALA) Recent Developments
  85. 8.15 Brilliant Bio Pharma
  86. 8.15.1 Brilliant Bio Pharma Company Information
  87. 8.15.2 Brilliant Bio Pharma Business Overview
  88. 8.15.3 Brilliant Bio Pharma Hemorrhagic Septicemia Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Brilliant Bio Pharma Hemorrhagic Septicemia Vaccines Product Portfolio
  90. 8.15.5 Brilliant Bio Pharma Recent Developments
  91. 8.16 Bio-Labs (PVT) Limited
  92. 8.16.1 Bio-Labs (PVT) Limited Company Information
  93. 8.16.2 Bio-Labs (PVT) Limited Business Overview
  94. 8.16.3 Bio-Labs (PVT) Limited Hemorrhagic Septicemia Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Bio-Labs (PVT) Limited Hemorrhagic Septicemia Vaccines Product Portfolio
  96. 8.16.5 Bio-Labs (PVT) Limited Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Hemorrhagic Septicemia Vaccines Value Chain Analysis
  2. 9.1.1 Hemorrhagic Septicemia Vaccines Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Hemorrhagic Septicemia Vaccines Production Mode & Process
  6. 9.2 Hemorrhagic Septicemia Vaccines Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Hemorrhagic Septicemia Vaccines Distributors
  9. 9.2.3 Hemorrhagic Septicemia Vaccines Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst